Auddia entered into four senior unsecured bridge notes totaling up to $1.4 million with Thramann Holdings and its portfolio companies LT350, Influence Healthcare, and Voyex to provide interim funding while a pending merger is finalized. The notes carry 8% annual interest, are unsecured and senior, and mature upon the earlier of a change of control or two years after any termination of the merger agreement. Notes for LT350, Influence Healthcare, and Voyex include automatic conversion at 80% of price upon Qualified Financings meeting specified thresholds; Thramann Holdings’ note is not convertible. All funded amounts will count toward Auddia’s $12 million net cash closing condition under the merger agreement.

Agreement 1: Auddia Extends $360,000 8% Senior Bridge Note to Thramann Holdings Ahead of Merger

  • Agreement type: Senior unsecured bridge note at 8% interest
  • Counterparty: Thramann Holdings
  • Signed / Effective: Jul 17 2026 / same
  • Duration / Termination: Earlier of change of control or two years after merger termination
  • Reason: Provide interim funding while merger is pending

Agreement 2: Auddia Provides $400,000 8% Convertible Bridge Note to LT350 Amid Pending Merger

  • Agreement type: Senior unsecured convertible bridge note at 8% interest
  • Counterparty: LT350
  • Signed / Effective: Jul 17 2026 / same
  • Duration / Termination: Earlier of change of control or two years after merger termination
  • Reason: Provide interim funding while merger is pending

Agreement 3: Auddia Issues $590,000 8% Convertible Bridge Note to Influence Healthcare

  • Agreement type: Senior unsecured convertible bridge note at 8% interest
  • Counterparty: Influence Healthcare
  • Signed / Effective: Jul 17 2026 / same
  • Duration / Termination: Earlier of change of control or two years after merger termination
  • Reason: Provide interim funding while merger is pending

Agreement 4: Auddia Executes $50,000 8% Convertible Bridge Note With Voyex

  • Agreement type: Senior unsecured convertible bridge note at 8% interest
  • Counterparty: Voyex
  • Signed / Effective: Jul 17 2026 / same
  • Duration / Termination: Earlier of change of control or two years after merger termination
  • Reason: Provide interim funding while merger is pending

Original SEC Filing:

This is an AI-powered summary. It may contain inaccuracies. Consider verifying important information with the source. Please note this summary is solely based on documents filed with the SEC.